Thank you for being a subscriber - we couldn't do it without you! - Susan and Pascale

Find this information useful? YubaNet is powered by your subscription

$
$
$

Your contribution is appreciated.

Posted inLife

Restasis: Why US consumers paid billions for drug deemed ineffective in other countries

Jan. 4, 2018 – Why are Americans, both as patients and taxpayers, paying billions of dollars for a drug whose efficacy is so questionable that it’s not approved in the European Union, Australia or New Zealand? Restasis, a blockbuster drug sold by Allergan to treat chronic dry eye, has done $8.8 billion in U.S. sales […]